A novel joint atmospheric turbulence (AT) detection and adaptive demodulation technique based on convolutional neural network (CNN) are proposed for the OAM-based free-space optical (FSO) communication. The AT detecting accuracy (ATDA) and the adaptive demodulating accuracy (ADA) of the 4-OAM, 8-OAM, 16-OAM FSO communication systems over computer-simulated 1000-m turbulent channels with 4, 6, 10 kinds of classic ATs are investigated, respectively. Compared to previous approaches using the self-organizing mapping (SOM), deep neural network (DNN) and other CNNs, the proposed CNN achieves the highest ATDA and ADA due to the advanced multi-layer representation learning without feature extractors designed carefully by numerous experts. For the AT detection, the ATDA of CNN is near 95.2% for 6 kinds of typical ATs, in cases of both weak and strong ATs. For the adaptive demodulation of optical vortices (OV) carrying OAM modes, the ADA of CNN is about 99.8% for the 8-OAM system over the computer-simulated 1000-m free-space strong turbulent link. In addition, the effects of image resolution, iteration number, activation functions and the structure of the CNN are also studied comprehensively. The proposed technique has the potential to be embedded in charge-coupled device (CCD) cameras deployed at the receiver to improve the reliability and flexibility for the OAM-FSO communication.
Dynamically imaging stochastic collision electrochemistry of single nanoparticles by electrochemiluminescence microscopy enables visualization of diverse collision behaviours.
A bio‐coreactant‐enhanced electrochemiluminescence (ECL) microscopy realizes the ECL imaging of intracellular structure and dynamic transport. This microscopy uses Ru(bpy)32+ as the electrochemical molecular antenna connecting extracellular and intracellular environments, and uses intracellular biomolecules as the coreactants of ECL reactions via a “catalytic route”. Accordingly, intracellular structures are identified without using multiple labels, and autophagy involving DNA oxidative damage is detected using nuclear ECL signals. A time‐resolved image sequence discloses the universal edge effect of cellular electroporation due to the influence of the geometric properties of cell membranes on the induced transmembrane voltage. The dynamic transport of Ru(bpy)33+ in the different cellular compartments unveils the heterogeneous intracellular diffusivity correlating with the actin cytoskeleton. In addition to single‐cell studies, the bio‐coreactant‐enhanced ECL microscopy is used to image a slice of a mouse liver and a colony of Shewanella oneidensis MR‐1.
The development of versatile nanotheranostic platforms that integrate both diagnostic and therapeutic functions have always been an intractable challenge in precise cancer treatment. Herein, an aptamer‐tethered deoxyribonucleic acids‐gold particle (Apt‐DNA‐Au) nanomachine has been developed for in situ imaging and targeted multimodal synergistic therapy of mammary carcinoma. Upon specifically internalized into MCF‐7 cells, the tumor‐related TK1 mRNA activates the Apt‐DNA‐Au nanomachine by DNA strand displacement cascades, resulting in the release of the fluorophore and antisense DNA as well as the aggregation of AuNPs for in situ imaging, suppression of survivin expression and photothermal therapy, respectively. Meanwhile, the controlled released drugs are used for chemotherapy, while under the laser irradiation the loaded photosensitizer produces reactive oxygen species (ROS) for photodynamic therapy. The results confirm that the proposed Apt‐DNA‐Au nanomachine provides a powerful nanotheranostic platform for in situ imaging‐guided combinatorial anticancer therapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.